Through
11/26
WHO: Johannes Eichstaedt Graduate student, Department of Psychology
“In today’s world, the stereotype of the nerdy scientist, by himself, looking at a microscope, is no longer accurate and no longer useful,” says Gabriel Innes, a third-year student in the University of Pennsylvania School of Veterinary Medicine.
University of Pennsylvania senior Steve Scarfone and junior Jeffrey Ng are part of a local community-engagement project that mixes volunteering and increasing access to learning through Penn Science Across Ages.
When the human genome was first sequenced, experts predicted they would find about 100,000 genes. The actual number has turned out to be closer to 20,000, just a few thousand more than fruit flies have. The question logically arose: how can a relatively small number of genes lay the blueprint for the complexities of the human body?
Interdisciplinary research at the University of Pennsylvania is showing how cells interact over long distances within fibrous tissue, like that associated with many diseases of the liver, lungs and other organs.
At the turn of the millennium, the cost to sequence a single human genome exceeded $50 million, and the process took a decade to complete. Microbes have genomes, too, and the first reference genome for a malaria parasite was completed in 2002 at a cost of roughly $15 million. But today researchers can sequence a genome in a single afternoon for just a few thousand dollars.
Professors James Eberwine, of the University of Pennsylvania’s Perelman School of Medicine and Shu Yang, of Penn’s School of Engineering and Applied Science, have been
By Christina Cook
Origami is capable of turning a simple sheet of paper into a pretty paper crane, but the principles behind the paper-folding art can also be applied to making a microfluidic device for a blood test, or for storing a satellite's solar panel in a rocket’s cargo bay.
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
In a Q&A, PIK Professor Duncan Watts says that U.S. voters ignored Democratic policy in favor of Republican storytelling.
FULL STORY →
Michael Mann of the School of Arts & Sciences discusses how much a president can do or undo when it comes to environmental policy.
FULL STORY →
Michael Mann of the School of Arts & Sciences voices his concern about the possibility that the U.S. could become a petrostate.
FULL STORY →
Mingmin Zhao of the School of Engineering and Applied Science and colleagues are using radio signals to allow robots to “see” beyond traditional sensor limits.
FULL STORY →
Amy Gutmann Hall aims to be Philadelphia’s next big hub for AI and innovation while setting a new standard for architectural sustainability.
FULL STORY →
Michael Mann of the School of Arts & Sciences says that total carbon emissions including fossil fuel pollution and land use changes such as deforestation are basically flat because land emissions are declining.
FULL STORY →
Jennifer Wilcox of the School of Engineering and Applied Science and Kleinman Center for Energy Policy at the Weitzman School of Design says that the carbon-removal potential of forestation can’t always be reliably measured in terms of how much removal and for how long.
FULL STORY →
Danny Cullenward of the Kleinman Center for Energy Policy at the Weitzman School of Design says that many things being credited in California’s new climate program don’t help the climate.
FULL STORY →
A collaborative study by researchers from the School of Engineering and Applied Science has shed new light on amorphization, the transition from a crystalline to a glassy state at the nanoscale.
FULL STORY →
Michael Mann of the School of Arts & Sciences says that a second Trump term and the implementation of Project 2025 represents the end of climate action in this decade.
FULL STORY →